Show
Sort by
-
- Journal Article
- A1
- open access
Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer
-
- Journal Article
- A1
- open access
European experts consensus : BRCA/homologous recombination deficiency testing in first-line ovarian cancer
-
Homologous recombination repair deficiency (HRD) testing in newly diagnosed advanced-stage epithelial ovarian cancer : a Belgian expert opinion
-
- Journal Article
- A1
- open access
Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer
-
- Journal Article
- A2
- open access
Treatment algorithm in patients with ovarian cancer
-
Treatment of ovarian cancer with intraperitoneal platinum : heating up the debate
-
Advanced ovarian cancer: primary or interval debulking? : five categories of patients in view of the results of randomize trials and tumor biology : primary debulking surgery an interval debulking surgery for advanced ovarian cancer
-
Completion surgery after intensity-modulated arc therapy in the treatment of locally advanced cervical cancer feasibility, surgical outcome, and oncologic results
-
Value of magnetic resonance and 18FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy : a prospective pathology-matched study
-
Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer : toxicity, tumour response and outcome